source
- Galderma receives FDA complete response letter for anti-wrinkle neuromodulatorGalderma has been issued a complete response letter by the U.S. Food and Drug Administration for its experimental anti-wrinkle product relabotulinumtoxinA, which was under review as a neuromodulato…
- U.S. Judge Blocks Colorado Panel’s Attempt to Cap Amgen’s Enbrel PriceA federal judge in the United States issued an order that prevents a Colorado state panel from imposing a price cap on Amgen’s blockbuster arthritis drug Enbrel. The ruling effectively blocks the s…